Mayo Clinic Board of Trustees Selects Matthew R. Callstrom, M.D., Ph.D., as next president and CEO

Mayo Clinic

The Mayo Clinic Board of Trustees has elected Matthew R. Callstrom, M.D., Ph.D., as its next president and CEO. Dr. Callstrom will succeed Gianrico Farrugia, M.D., in this top executive role. Meanwhile, Dr. Farrugia will continue serving as president and CEO through December 31, 2026. During this period, he will work closely with Dr. Callstrom to guarantee a smooth leadership transition.

“Dr. Callstrom is an accomplished physician-scientist and enterprise leader who brings nearly 25 years of experience at Mayo Clinic and a deep commitment to our values and mission,” says Richard K. Davis, chair, Mayo Clinic Board of Trustees. “His leadership across patient care, research, strategy and innovation, combined with his ability to translate scientific discovery and emerging technology into meaningful advances for patients, prepares him exceptionally well to lead Mayo Clinic into its next chapter.”

Dr. Callstrom’s Leadership and AI Innovation Experience

Specifically, Dr. Callstrom first joined Mayo Clinic back in 2002. Over the past two decades, he has held major leadership roles across clinical practice, research, strategy, and AI. Currently, he sits on both the Board of Governors and the Board of Trustees. Furthermore, he acts as the medical director for Mayo Clinic Strategy and the AI Program. Previously, he also served as interim chief strategy officer and chair of the Department of Radiology in Rochester.

Across these positions, Dr. Callstrom shaped organizational strategy and championed the responsible use of AI in medicine. Consequently, his efforts accelerate new cures and help clinicians detect diseases much earlier. These technological tools also empower doctors to treat patients facing serious and complex medical conditions.

“I am deeply honored to have the opportunity to lead Mayo Clinic in this moment, serving alongside colleagues whose expertise, curiosity and commitment to our patients inspire me every day,” says Dr. Callstrom. “Mayo Clinic has always been at its best when we bring the full power of our clinical expertise, science and innovation to the needs of the patient. Now, we have an opportunity to build on that foundation accelerating the translation of discovery and emerging technologies into better care and extending Mayo Clinic’s impact to more patients, wherever they are.”

Clinical Background and Pioneering Cancer Research

Throughout his career, Dr. Callstrom has worked at the intersection of patient care, science, and innovation. As a body interventional radiologist, global medical communities recognize him for advancing image-guided cancer treatments. For instance, he develops advanced technologies that pinpoint and treat tumors with greater precision. Moreover, he has led numerous clinical trials and produced over 200 medical publications and patents. In addition, peers named him a Mayo Clinic Distinguished Clinician and president of the Society of Interventional Oncology.

“Dr. Callstrom combines a deep understanding of Mayo Clinic with the ability to see what is coming next and bring people together to turn possibility into meaningful change for patients,” Davis says. “He understands Mayo Clinic as a physician caring for patients, a scientist translating discovery into clinical care and a leader shaping our strategy for the future. That combination is invaluable as Mayo Clinic continues to advance its mission and transform healthcare.”

Originally a Minnesota native, Dr. Callstrom earned chemical engineering and chemistry degrees from the University of Minnesota Twin Cities. Afterward, he completed a postdoctoral fellowship at Harvard University. He then earned his medical degree from Mayo Clinic Alix School of Medicine. Finally, he finished his diagnostic radiology residency and cross-sectional imaging fellowship in Rochester.

Building on Dr. Farrugia’s Transformative Legacy

Ultimately, Dr. Callstrom steps into the role previously held by Dr. Farrugia since 2019. Under Dr. Farrugia’s guidance, Mayo Clinic launched its ambitious Bold. Forward. healthcare transformation strategy. As a result, the organization accelerated the discovery and delivery of cures for chronic and acute diseases. It also connected people with data to build scalable healthcare solutions. Most notably, the institution launched Mayo Clinic Platform, its first comprehensive, AI-enabled care transformation network.

“Dr. Farrugia has led Mayo Clinic through a period of extraordinary transformation and progress while remaining steadfastly focused on our primary value: the needs of the patient come first,” Davis says. “His leadership has strengthened Mayo Clinic and created tremendous momentum for the future. The Board is deeply grateful for Dr. Farrugia’s continued service and contributions, including significant investments in Mayo Clinic’s people, physical and digital infrastructure, education, research, AI and new care models, which leave Mayo Clinic so well positioned for its next chapter.”

“It has been the privilege of my career to serve as president and CEO of Mayo Clinic and to work alongside extraordinary colleagues who share an unwavering commitment to patients,” says Dr. Farrugia. “Dr. Callstrom knows Mayo Clinic deeply, understands where healthcare is headed and has the vision and experience to build on the progress we have made. I have great confidence in him and in Mayo Clinic’s future.”

For more stories on executive leadership and business innovations, explore our CXO Insiders for the latest updates.

Source: PRNewswire

Share with friends

Latest News

CXO Insiders